Castleark Management’s Edwards Lifesciences EW Stock Holding History

Castleark Management’s Portfolio EW Stock Details EW Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-181,595	Closed	-$13.5M	–	297
2022 Q4	$13.5M	Sell	181,595 -239,900	-57%	-$17.9M	0.71%	34
2022 Q3	$34.8M	Buy	421,495 +8,530	+2%	+$705K	1.94%	12
2022 Q2	$39.3M	Buy	412,965 +46,150	+13%	+$4.39M	2.1%	14
2022 Q1	$43.2M	Sell	366,815 -19,680	-5%	-$2.32M	1.86%	15
2021 Q4	$50.1M	Sell	386,495 -840	-0.2%	-$109K	1.84%	14
2021 Q3	$43.9M	Sell	387,335 -51,950	-12%	-$5.88M	1.68%	13
2021 Q2	$45.5M	Buy	439,285 +205,240	+88%	+$21.3M	1.53%	16
2021 Q1	$19.6M	Buy	234,045 +12,150	+5%	+$1.02M	0.7%	36
2020 Q4	$20.2M	Sell	221,895 -6,035	-3%	-$551K	0.76%	35
2020 Q3	$18.2M	Buy	227,930 +27,520	+14%	+$2.2M	0.71%	36
2020 Q2	$13.9M	Buy	200,410 +197,240	+6,222%	+$13.6M	0.6%	38
2020 Q1	$598K	Buy	3,170 +1,730	+120%	+$326K	0.04%	218
2019 Q4	$336K	Sell	1,440 -1,080	-43%	-$252K	0.01%	299
2019 Q3	$554K	Hold	2,520	–	–	0.02%	274
2019 Q2	$466K	Sell	2,520 -1,470	-37%	-$272K	0.02%	295
2019 Q1	$763K	Hold	3,990	–	–	0.03%	275
2018 Q4	$611K	Sell	3,990 -76,260	-95%	-$11.7M	0.03%	284
2018 Q3	$14M	Sell	80,250 -97,147	-55%	-$16.9M	0.4%	84
2018 Q2	$25.8M	Buy	177,397 +174,207	+5,461%	+$25.4M	0.79%	27
2018 Q1	$445K	Buy	3,190 +730	+30%	+$102K	0.01%	318
2017 Q4	$277K	Buy	2,460 +890	+57%	+$100K	0.01%	347
2017 Q3	$172K	Sell	1,570 -96,030	-98%	-$10.5M	0.01%	362
2017 Q2	$11.5M	Sell	97,600 -78,104	-44%	-$9.23M	0.38%	85
2017 Q1	$16.5M	Sell	175,704 -149,679	-46%	-$14.1M	0.52%	45
2016 Q4	$30.5M	Sell	325,383 -203,947	-39%	-$19.1M	0.97%	22
2016 Q3	$63.8M	Sell	529,330 -27,970	-5%	-$3.37M	1.93%	1
2016 Q2	$55.6M	Sell	557,300 -52,880	-9%	-$5.27M	1.77%	6
2016 Q1	$53.8M	Buy	610,180 +43,430	+8%	+$3.83M	1.68%	9
2015 Q4	$44.8M	Buy	566,750 +278,650	+97%	+$22M	1.35%	20
2015 Q3	$41M	Sell	288,100 -12,200	-4%	-$1.73M	1.32%	21
2015 Q2	$42.8M	Buy	300,300 +160,220	+114%	+$22.8M	1.14%	20
2015 Q1	$20M	Buy	+140,080	New	+$20M	0.48%	50